PIK3CG Antibody

What is PIK3CG and why is it important in research?

PIK3CG encodes the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, a critical enzyme that phosphorylates inositol lipids and participates in immune response signaling pathways. Unlike other class I PI3K family members that signal downstream of receptor tyrosine kinases, PIK3CG (p110 gamma) is the sole class IB phosphatidylinositol 3-kinase that primarily signals downstream of G protein-coupled receptors (GPCRs) . It functions by phosphorylating phosphoinositides on the 3-hydroxyl group of the inositol ring, generating the important second messenger PIP2 . PIK3CG is particularly significant in research because it modulates extracellular signals, including those involved in E-cadherin-mediated cell-cell adhesion, and plays a pivotal role in maintaining epithelial structural and functional integrity . Recent studies have also demonstrated its importance in promoting antibody responses induced by T cell-dependent antigens .

What applications are PIK3CG antibodies validated for?

PIK3CG antibodies have been validated for multiple applications across various experimental platforms. Most commercially available antibodies are tested and confirmed for Western Blotting (WB), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), and Flow Cytometry . Many antibodies also demonstrate utility in Immunofluorescence (IF) and Immunocytochemistry (ICC) . When selecting a PIK3CG antibody, verification of the specific applications is essential, as different clones may vary in their performance across applications. For instance, the Picoband® anti-PI3K-gamma/PIK3CG antibody (A01517-2) has been specifically validated for ELISA, Flow Cytometry, IHC, and WB applications across human, mouse, and rat samples .

How should I select the appropriate PIK3CG antibody for my experimental needs?

When selecting a PIK3CG antibody, consider the following methodological approach:

• Species reactivity: Confirm the antibody reacts with your species of interest. Many PIK3CG antibodies react with human samples, but fewer are validated for mouse or rat models .

• Application compatibility: Verify that the antibody is validated for your specific application (WB, IHC, IF, ELISA, Flow Cytometry) .

• Epitope recognition: Consider which region of PIK3CG the antibody targets. Antibodies are available that recognize different regions (e.g., AA 1-100, AA 1-200, C-terminal) . This choice may be particularly important if studying specific domains or truncated forms.

• Clonality: Monoclonal antibodies provide consistent results with high specificity for a single epitope, while polyclonal antibodies can offer higher sensitivity by recognizing multiple epitopes .

• Validation evidence: Review the available validation data, including Western blot images showing the expected 126 kDa band and IHC/IF images demonstrating appropriate cellular localization .

What controls should I include when using PIK3CG antibodies?

Proper experimental controls are essential for reliable results with PIK3CG antibodies:

• Positive control: Include samples known to express PIK3CG. Cell lines such as K562, Raji, Jurkat, HepG2, NIH/3T3, and RAW264.7 have been validated to express detectable levels of PIK3CG .

• Negative control: For flow cytometry, include an isotype control antibody (matching the host species and isotype of your primary antibody) to assess non-specific binding .

• Loading control: For Western blots, include a housekeeping protein control (e.g., GAPDH, β-actin) to normalize protein loading.

• Secondary antibody only control: Include a sample with only the secondary antibody to detect any non-specific binding of the secondary antibody.

• Knockdown/knockout validation: When possible, include PIK3CG knockdown or knockout samples to confirm antibody specificity.

How can I optimize Western blot protocols for PIK3CG detection?

Optimizing Western blot protocols for PIK3CG detection requires careful attention to several technical aspects:

• Sample preparation:

  • Use appropriate lysis buffers containing phosphatase inhibitors to preserve the phosphorylation state of PIK3CG and associated proteins

  • Load sufficient protein (approximately 50μg per lane) to detect PIK3CG, which has a calculated molecular weight of 126.454 kDa

• Gel electrophoresis:

  • Use 5-20% gradient SDS-PAGE gels for optimal separation of the high molecular weight PIK3CG protein

  • Run stacking gel at 70V and resolving gel at 90V for 2-3 hours to ensure proper separation

• Transfer conditions:

  • Transfer to nitrocellulose membrane at 150mA for 50-90 minutes to ensure complete transfer of the large protein

• Blocking and antibody incubation:

  • Block membrane with 5% non-fat milk in TBS for 1.5 hours at room temperature

  • Incubate with primary antibody at the optimized concentration (e.g., 0.25 μg/mL) overnight at 4°C

  • Wash thoroughly with TBS-0.1% Tween (3 times, 5 minutes each)

  • Incubate with appropriate HRP-conjugated secondary antibody (e.g., 1:10000 dilution) for 1.5 hours at room temperature

• Detection:

  • Use enhanced chemiluminescent (ECL) detection for optimal sensitivity

  • Expect to observe a specific band at approximately 126 kDa for PIK3CG

How do I troubleshoot weak or non-specific signals in PIK3CG immunodetection?

When encountering weak or non-specific signals when working with PIK3CG antibodies, consider the following troubleshooting approaches:

• For weak signals:

  • Increase primary antibody concentration or incubation time

  • Optimize protein loading (50μg is recommended for PIK3CG detection)

  • Use more sensitive detection methods (e.g., enhanced ECL substrates)

  • Reduce the number or stringency of washing steps

  • Ensure target protein is not degraded during sample preparation by using fresh samples and appropriate protease inhibitors

• For non-specific bands:

  • Increase blocking time or concentration (try 5% BSA instead of milk for phospho-specific detection)

  • Reduce primary antibody concentration

  • Increase washing steps or detergent concentration in wash buffer

  • Use monoclonal antibodies for higher specificity

  • Confirm antibody specificity using genetic knockdown controls

• For high background:

  • Ensure adequate blocking (try different blocking agents like BSA or casein)

  • Reduce secondary antibody concentration

  • Use fresher reagents, especially ECL substrate

  • Check for contamination in washing solutions

How can I optimize immunohistochemistry protocols for PIK3CG detection in tissue samples?

Optimizing immunohistochemistry for PIK3CG detection requires careful attention to antigen retrieval and staining conditions:

• Fixation and embedding:

  • Use 10% neutral buffered formalin for fixation

  • Limit fixation time to prevent excessive cross-linking

• Sectioning:

  • 4-5 μm thick sections are typically optimal for PIK3CG detection

• Antigen retrieval:

  • Heat-mediated antigen retrieval in EDTA buffer (pH 8.0) has been validated for PIK3CG detection

  • Optimize retrieval time based on tissue type and fixation conditions

• Blocking:

  • Block with 10% goat serum (or serum from the species of secondary antibody) to minimize non-specific binding

• Antibody incubation:

  • Use optimized antibody concentration (approximately 2 μg/ml has been validated)

  • Incubate overnight at 4°C for optimal binding

• Detection system:

  • Streptavidin-Biotin-Complex (SABC) with DAB chromogen has been successfully used for PIK3CG detection

  • Consider amplification systems for weakly expressed targets

• Counterstaining:

  • Use light hematoxylin counterstaining to visualize tissue architecture without obscuring specific staining

How is PIK3CG involved in B cell function and antibody responses?

Recent research has revealed significant roles for PIK3CG in B cell function and antibody production:

PIK3CG has been shown to promote robust antibody responses induced by T cell-dependent antigens . While the requirement for PI3Kδ in B cell biology has been extensively studied, the specific functions of PI3Kγ in B lineage cells were less well characterized until recently. New research demonstrates that:

• PI3Kγ functions cell-intrinsically within activated B cells in a kinase activity-dependent manner

• PI3Kγ transduces signals required for the transcriptional program that supports differentiation of antibody-secreting cells (ASCs)

• Human deficiency in PI3Kγ results in broad humoral defects, suggesting its critical role in normal antibody production

This finding has significant implications for understanding immune disorders characterized by antibody deficiencies and may provide new therapeutic targets for modulating antibody responses in various disease contexts.

What are the key considerations when interpreting PIK3CG expression data across different tissue types?

When interpreting PIK3CG expression data across tissue types, researchers should consider several important factors:

• Tissue-specific expression patterns:

  • PIK3CG is most abundantly expressed in leukocytes and tissues rich in immune cells

  • Expression levels vary significantly across different cell types, with high expression in myeloid and lymphoid cells

• Subcellular localization:

  • PIK3CG protein may show different subcellular localization patterns depending on activation state

  • Consider whether nuclear, cytoplasmic, or membrane staining is expected based on cell type and condition

• Context-dependent signaling:

  • PIK3CG activity and expression may be altered in disease states, particularly in cancers and inflammatory conditions

  • Compare expression with appropriate normal tissue controls

• Technical considerations:

  • Different antibodies may detect different isoforms or phosphorylation states

  • Validation across multiple techniques (WB, IHC, IF) strengthens interpretation

  • Quantitative techniques like Western blot should be used alongside qualitative methods like IHC

• Species differences:

  • PIK3CG expression and function may vary between species, necessitating species-specific validation

How do I design experiments to study PIK3CG pathway activation and inhibition?

Designing experiments to study PIK3CG pathway activation and inhibition requires careful planning:

• Pathway activation experiments:

  • Stimulate cells with GPCR agonists known to activate PIK3CG (e.g., chemokines, formyl peptides)

  • Monitor downstream effects using phospho-specific antibodies against AKT (Ser473, Thr308)

  • Assess membrane translocation of PIK3CG using fractionation or imaging techniques

  • Use positive controls such as known PIK3CG-expressing cell lines (K562, Raji, Jurkat)

• Inhibition studies:

  • Use small molecule inhibitors with selectivity for PIK3CG

  • Consider genetic approaches such as siRNA, shRNA, or CRISPR-Cas9 for PIK3CG knockout

  • Include appropriate controls: vehicle control, non-targeting siRNA, and PI3K isoform-selective inhibitors

• Readouts:

  • Measure phosphorylation of direct downstream targets

  • Assess functional outcomes relevant to the biological context (e.g., chemotaxis, ROS production in neutrophils; antibody production in B cells)

  • Consider multi-parameter flow cytometry to analyze pathway activation at the single-cell level

• Validation:

  • Confirm specificity of effects using multiple approaches

  • Perform rescue experiments with wild-type vs. kinase-dead PIK3CG constructs

How can PIK3CG antibodies be used to study its role in cancer and immune disorders?

PIK3CG antibodies serve as critical tools for investigating this kinase's role in cancer and immune disorders:

• Cancer research applications:

  • Assess PIK3CG expression in tumor samples via IHC to correlate with patient outcomes

  • Study alterations in PIK3CG signaling in myeloid leukemias, as the gene is located in a commonly deleted segment of chromosome 7

  • Investigate PIK3CG's role in tumor-associated macrophages and myeloid-derived suppressor cells, where it may promote immunosuppression

  • Monitor therapy responses to PI3K pathway inhibitors using phospho-specific antibodies

• Immune disorder applications:

  • Evaluate PIK3CG expression and activity in primary immune cells from patients with suspected PIK3CG deficiency

  • Investigate PIK3CG's role in B cell differentiation and antibody production, which has implications for humoral immunodeficiencies

  • Study inflammatory pathway activation in autoimmune conditions

  • Assess PIK3CG as a biomarker for disease activity or treatment response

What are the emerging techniques for studying PIK3CG protein-protein interactions and signaling complexes?

Several advanced techniques are being applied to study PIK3CG protein-protein interactions:

• Proximity ligation assay (PLA):

  • Enables visualization of protein-protein interactions in situ

  • Can detect endogenous PIK3CG interactions with regulatory subunits or downstream effectors

  • Some PIK3CG antibodies are specifically validated for PLA applications

• Co-immunoprecipitation coupled with mass spectrometry:

  • Identifies novel interaction partners of PIK3CG in different cellular contexts

  • Requires highly specific antibodies suitable for immunoprecipitation

  • Can reveal context-dependent interactome changes

• FRET/BRET-based assays:

  • Monitors real-time protein interactions in living cells

  • Can detect conformational changes in PIK3CG upon activation

  • Useful for high-throughput screening of compounds affecting PIK3CG interactions

• Phosphoproteomics:

  • Identifies the full spectrum of downstream targets affected by PIK3CG activity

  • Can be combined with PIK3CG inhibition or knockdown to identify specific substrates

• BioID or APEX proximity labeling:

  • Maps the spatial proteome surrounding PIK3CG in different subcellular compartments

  • Helps identify transient or weak interactions missed by traditional co-IP

How do different PIK3CG antibody clones compare in detecting specific phosphorylation states or protein conformations?

Different antibody clones vary in their ability to detect specific states of PIK3CG:

• Epitope specificity:

  • Antibodies targeting different regions (N-terminal, C-terminal, internal domains) may have different sensitivities to conformational changes in PIK3CG

  • Commercially available antibodies target various regions including AA 1-100, AA 1-200, and C-terminal regions of PIK3CG

• Phosphorylation-state specificity:

  • Some antibodies may have reduced binding when PIK3CG is phosphorylated at specific residues

  • Phospho-specific antibodies can directly detect activated states of PIK3CG

  • Consider using phosphatase inhibitors during sample preparation to preserve physiologically relevant phosphorylation states

• Comparative performance:

  • When studying PIK3CG conformational changes or activation states, it may be valuable to use multiple antibody clones targeting different epitopes

  • Validation across multiple techniques strengthens confidence in observed changes

• Application-specific considerations:

  • For detecting native protein complexes, select antibodies validated for immunoprecipitation or proximity ligation assays

  • For detecting denatured protein in Western blots, antibodies recognizing linear epitopes may perform better

What are the emerging research questions regarding PIK3CG in cross-talk with other signaling pathways?

Several exciting research questions are emerging regarding PIK3CG's interactions with other signaling networks:

• Integration with other PI3K isoforms:

  • How does PIK3CG functionally interact with class IA PI3Ks in cells expressing multiple isoforms?

  • What determines the relative contribution of different PI3K isoforms to cellular responses?

• Cross-talk with non-PI3K pathways:

  • How does PIK3CG signaling integrate with MAPK, JAK/STAT, or other signaling cascades?

  • What is the role of PIK3CG in non-canonical signaling pathways independent of lipid kinase activity?

• Regulatory mechanisms:

  • What are the post-translational modifications that regulate PIK3CG activity?

  • How do different regulatory subunits affect PIK3CG function in different cell types?

• Spatial signaling:

  • How is PIK3CG activity regulated within specific subcellular compartments?

  • What determines the recruitment of PIK3CG to specific membrane domains?

• B cell antibody responses:

  • What are the molecular mechanisms by which PIK3CG promotes the transcriptional program for antibody-secreting cell differentiation?

  • How does PIK3CG collaborate with other signaling molecules to regulate humoral immunity?

How can multiplexed antibody approaches advance our understanding of PIK3CG in complex tissues?

Multiplexed antibody approaches offer powerful new ways to study PIK3CG in complex biological systems:

• Multiplex immunohistochemistry/immunofluorescence:

  • Simultaneously visualizes PIK3CG expression alongside multiple cell type markers

  • Enables spatial analysis of PIK3CG expression in the tissue microenvironment

  • Can correlate PIK3CG expression with activation of downstream pathways in specific cell types

• Mass cytometry (CyTOF):

  • Measures PIK3CG expression and activation alongside dozens of other parameters at single-cell resolution

  • Identifies rare cell populations with unique PIK3CG signaling profiles

  • Requires metal-conjugated antibodies validated for CyTOF applications

• Single-cell proteomics:

  • Maps PIK3CG-dependent signaling networks at single-cell resolution

  • Reveals heterogeneity in PIK3CG expression and activity within seemingly homogeneous populations

• Spatial transcriptomics combined with protein detection:

  • Correlates PIK3CG protein expression with transcriptional profiles in spatial context

  • Provides insights into the functional consequences of PIK3CG activation

• Digital spatial profiling:

  • Quantifies PIK3CG expression in precisely defined regions of interest within complex tissues

  • Enables high-plex protein analysis with spatial resolution